Apirol
Apirol, licence 80055367: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Fabrication JAMP Pharma Inc. / JAMP Manufacturing Inc.
- NPN or DIN-HM
- 80055367
- Status
- Inactive licence
- Licence date
- 3 November 2014
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Gelée royale Source : Apis mellifera - sécrétion | 375.4 mg | Not calculated |
Non-medicinal ingredients
Sorbate de potassium, Benzoate de sodium, Glycérine, miel, Eau purifiée, Alcool éthylique, Sorbitol solution, non-crystallizing, Vitamine C
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Cuillière(s) à table | 3.0 Tous les jours |
Uses authorised in Canada
Supplément alimentaire fournissant des antioxydants. Utilisé en photothérapie comme tonique nutritif.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Si vous avez des antécédents d'asthme ou d'allergie, ne pas utiliser ce produit.
- Effets indésirables connus
Une hypersensibilité, telle une allergie, peut se manifester. Si tel est le cas, cesser immédiatement l'utilisation.
Source
Official Health Canada record, licence 80055367
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.